Incidentally, other anticancer drugs also appear to disrupt the mitochondrial function of tumour cells as part of their action via the translocation of HO-1 into mitochondria, as has been shown for the isoflavone derivative ME-344 [60] and the nuclear factor (NF)-κB inhibitor BAY114085 [61]. This evidence concerns the gene HMOX1 and neoplasm.